While difficult to put a number on the minimal number of transcripts needed, studies on splice modulation therapy for USH1C-associated hearing loss indicate that 20% of functional USH1C transcripts is sufficient for inner ear function.36 The gene discussed is USH1C; the disease is hearing loss disorder.